Supreme Court of California

Affirming the Court of Appeals determination that the manufacturer of a name brand drug whose labeling directs the warnings provided on its generic bioequivalent's packaging owes a duty of reasonable care to the consumers of the generic drug and that the liability for potential negligence doesn't automatically terminate upon transfer of the company's rights in the name brand drug to a successor manufacturer.

Appellate Information

• Published 2017/12/21

Judges

• CUELLAR

Court

• Supreme Court of California

Counsel